Ticker: OVID

Ovid Therapeutics Inc. (NASDAQ: OVID) - Quick internal read What's happening inside: management is shrinking costs and pausing at least one program while pursuing strategic alternatives to extend runway. A one‑time Marinus payment boosted Q2 revenue; prior period's large "other income" was a one-...